Spero Therapeutics, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2017 | — | -5,427.9% | -4,197.1% |
| Jun 2017 | — | -4,082.3% | -3,682.3% |
| Sep 2017 | — | -1,669.3% | -1,647.6% |
| Dec 2017 | — | -1,409.9% | -1,396.0% |
| Mar 2018 | — | -938.1% | -923.2% |
| Jun 2018 | — | -2,153.6% | -2,150.3% |
| Sep 2018 | — | -1,661.9% | -1,590.1% |
| Dec 2018 | — | -655.1% | -626.4% |
| Mar 2019 | — | -73.8% | -66.1% |
| Jun 2019 | — | -633.2% | -612.2% |
| Sep 2019 | — | -387.4% | -381.2% |
| Dec 2019 | — | -3,718.8% | -3,589.9% |
| Mar 2020 | — | -1,341.6% | -1,369.8% |
| Jun 2020 | — | -1,069.8% | -1,013.3% |
| Sep 2020 | — | -476.1% | -473.1% |
| Dec 2020 | — | -985.6% | -975.4% |
| Mar 2021 | — | -265.8% | -265.8% |
| Jun 2021 | — | -360.2% | -361.3% |
| Sep 2021 | — | -735.1% | -734.3% |
| Dec 2021 | — | -1,002.3% | -1,067.8% |
| Mar 2022 | — | -1,460.0% | -1,585.3% |
| Jun 2022 | — | -1,308.6% | -1,440.0% |
| Sep 2022 | — | -589.9% | -583.3% |
| Dec 2022 | — | 54.6% | 56.5% |
| Mar 2023 | — | -687.6% | -642.8% |
| Jun 2023 | — | -474.6% | -438.1% |
| Sep 2023 | — | -7.6% | -12.6% |
| Dec 2023 | — | 68.7% | 69.6% |
| Mar 2024 | — | -150.9% | -136.7% |
| Jun 2024 | — | -186.9% | -175.2% |
| Sep 2024 | — | -138.0% | -127.3% |
| Dec 2024 | — | -144.4% | -138.8% |
| Mar 2025 | — | -250.8% | -236.1% |
| Jun 2025 | — | -17.2% | -12.0% |
| Sep 2025 | — | -145.5% | -135.6% |
| Dec 2025 | — | 76.0% | 76.3% |
| Mar 2026 | — | -2,921.7% | -2,791.9% |